---
title: Buy Kombiglyze XR 5/500 5/1000mg Pills Online
description: Kombiglyze XR (Saxagliptin metformin XR) 5/500mg, 5/1000mg controls type 2 diabetes. Trusted source for quality and delivery.
type: product
language: en 
url: https://ayudadiabetes.com/order-kombiglyze-xr-online-en
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 84.99
price_max: 1096.99
currency: USD
offers:
  - name: 5/500mg x 14 pills
    price: 84.99
  - name: 5/1000mg x 14 pills
    price: 96.99
  - name: 5/500mg x 28 pills
    price: 164.99
  - name: 5/1000mg x 28 pills
    price: 188.99
  - name: 5/500mg x 56 pills
    price: 324.99
  - name: 5/1000mg x 56 pills
    price: 374.99
  - name: 5/500mg x 84 pills
    price: 482.99
  - name: 5/1000mg x 84 pills
    price: 558.99
  - name: 5/500mg x 112 pills
    price: 637.99
  - name: 5/1000mg x 112 pills
    price: 738.99
  - name: 5/500mg x 168 pills
    price: 965.99
  - name: 5/1000mg x 168 pills
    price: 1096.99
---

# Buy Kombiglyze XR 5/500 5/1000mg Pills Online

Kombiglyze XR, combining Saxagliptin and extended-release Metformin, treats type 2 diabetes in adults. It enhances insulin response and lowers glucose production for better control. For patients requiring combination oral therapy. Available in 5/500mg and 5/1000mg pills online.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **5/500mg** | 14 pills | **$84.99** | $6.07 | In Stock |
| **5/1000mg** | 14 pills | **$96.99** | $6.93 | In Stock |
| **5/500mg** | 28 pills | **$164.99** | $5.89 | In Stock |
| **5/1000mg** | 28 pills | **$188.99** | $6.75 | In Stock |
| **5/500mg** | 56 pills | **$324.99** | $5.80 | In Stock |
| **5/1000mg** | 56 pills | **$374.99** | $6.70 | In Stock |
| **5/500mg** | 84 pills | **$482.99** | $5.75 | In Stock |
| **5/1000mg** | 84 pills | **$558.99** | $6.65 | In Stock |
| **5/500mg** | 112 pills | **$637.99** | $5.70 | In Stock |
| **5/1000mg** | 112 pills | **$738.99** | $6.60 | In Stock |
| **5/500mg** | 168 pills | **$965.99** | $5.75 | In Stock |
| **5/1000mg** | 168 pills | **$1096.99** | $6.53 | In Stock |


[Buy Now](https://ayudadiabetes.com/order-kombiglyze-xr-online-en)

## Introduction 

Kombiglyze XR is a fixed-dose combination tablet that contains the DPP-4 inhibitor saxagliptin together with extended-release metformin. It is prescribed for adults with type 2 diabetes mellitus when diet, exercise and metformin alone do not achieve adequate glycaemic control. The medication is supplied as a pill in two strengths - 5 mg/500 mg and 5 mg/1000 mg - and belongs to the therapeutic class of oral antidiabetic agents. Besides its primary role in managing blood glucose, the drug may be considered in patients who require a once-daily regimen that combines two complementary mechanisms of action.

## Quick Reference Facts 

**Active Ingredient** 
: Saxagliptin and metformin XR 

**Form** 
: pill 5/500 mg | 5/1000 mg 

**Primary and Off-Label Uses** 
: Type 2 diabetes mellitus 

## What is Kombiglyze XR? 

Kombiglyze XR is the generic version of medications containing the active compound saxagliptin and metformin XR. It combines a dipeptidyl-peptidase-4 (DPP-4) inhibitor with an extended-release biguanide, delivering two complementary glucose-lowering actions in a single once-daily tablet. The product is classified as an oral antidiabetic combination. Development of the fixed-dose formulation was driven by the need to simplify therapy for patients already taking separate saxagliptin and metformin tablets, improving adherence while maintaining the pharmacokinetic profiles of each component. While several brand-name versions exist, the generic formulation provides the same bioavailability and clinical efficacy at a lower cost. 

## How Kombiglyze XR Works 

Saxagliptin inhibits the DPP-4 enzyme, which normally degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). By preserving these hormones, saxagliptin enhances glucose-dependent insulin secretion and suppresses inappropriate glucagon release after meals, thereby lowering post-prandial glucose excursions. 

Metformin XR, on the other hand, acts principally by reducing hepatic gluconeogenesis, increasing peripheral insulin sensitivity, and modestly decreasing intestinal glucose absorption. The extended-release matrix allows a gradual release of metformin over 12-24 hours, providing steady plasma concentrations and reducing gastrointestinal irritation compared with immediate-release metformin. 

When combined, the two agents target both fasting and post-prandial hyperglycaemia. The onset of saxagliptin’s effect occurs within a few days, while metformin’s impact on hepatic glucose production becomes evident after about a week. Both components are eliminated primarily by the kidneys; saxagliptin is metabolised by CYP3A4, whereas metformin is excreted unchanged. This pharmacokinetic profile supports once-daily dosing, usually with the morning meal, and facilitates predictable drug levels in most patients with normal renal function.

## Conditions Treated with Kombiglyze XR 

- **Type 2 diabetes mellitus** - Kombiglyze XR improves glycaemic control by lowering both fasting plasma glucose and HbA₁c. Clinical trials demonstrated a mean HbA₁c reduction of approximately 0.5-0.8 % versus metformin alone, making it an effective add-on therapy for patients who have not reached target levels with metformin monotherapy. 

- **Adjunct to diet and exercise** - The medication is indicated as part of a comprehensive management plan that includes lifestyle modification. By providing dual mechanisms, it helps patients achieve glycaemic targets without the need for multiple separate pills. 

- **Patients requiring once-daily dosing** - The extended-release formulation of metformin, together with the long-acting profile of saxagliptin, enables a single-tablet regimen, which can enhance adherence, especially in individuals with complex medication schedules. 

These approved indications are recognised by regulatory agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).

## Is Kombiglyze XR the Right Medication for You? 

Kombiglyze XR is most suitable for adults with type 2 diabetes who are already taking metformin but need additional glucose-lowering effect. It is particularly advantageous for patients who prefer a single daily tablet rather than multiple separate agents. Those with moderate renal function (estimated glomerular filtration rate ≥ 45 mL/min/1.73 m²) can usually start the lower dose (5 mg/500 mg) and titrate upward if tolerated. 

Conversely, the drug is not appropriate for individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), a history of metabolic acidosis, or known hypersensitivity to saxagliptin, metformin, or any excipients. Caution is advised in patients with congestive heart failure, as metformin carries a theoretical risk of lactic acidosis in this setting. Patients already receiving insulin or sulfonylureas should be monitored closely for hypoglycaemia, as the additive glucose-lowering effect can increase this risk. 

Overall, the combination is recommended when the benefits of improved glycaemic control outweigh the potential for gastrointestinal side effects or rare metabolic complications.

## Buying Kombiglyze XR from [our online pharmacy](https://ayudadiabetes.com/order-kombiglyze-xr-online-en) 

### Why Choose Our Service? 
Accessing combination antidiabetic therapy can be difficult when local pharmacies face stock shortages or when insurance formularies restrict certain brands. Through our platform you can obtain Kombiglyze XR quickly and at a cost that reflects the generic market price. 

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and is verified by independent quality-control laboratories. 

### Pricing & Access 
Because Kombiglyze XR is offered as a generic formulation, the price is substantially lower than brand-name equivalents. This makes long-term therapy more affordable, especially for patients who require lifelong treatment. 

### Discreet Delivery 
Your order will be packaged in plain, unmarked parcels and dispatched with express delivery that typically arrives within seven days, or by standard airmail in approximately three weeks. All shipments respect patient privacy and include no identifying medication information on the outside. 

Choosing our pharmacy service means you receive a reliable, cost-effective supply of Kombiglyze XR while preserving confidentiality and convenience. 

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing** - The usual starting dose is one tablet of 5 mg/500 mg taken once daily with the first main meal. If tolerated, the dose may be increased to one tablet of 5 mg/1000 mg after at least two weeks. The total daily dose should not exceed two tablets. 
- **Missed dose** - If you forget to take a dose, take it as soon as you remember provided it is still within a reasonable time before the next scheduled dose. Do not double-dose; simply skip the missed tablet and continue with the regular dosing schedule. 
- **Overdose** - In the event of a suspected overdose, seek emergency medical attention immediately. Symptoms may include severe nausea, vomiting, abdominal pain, or signs of hypoglycaemia. Prompt treatment may involve supportive care, monitoring of blood glucose, and, if necessary, administration of activated charcoal for metformin. 
- **Practical precautions** - Kombiglyze XR should be taken with food to minimise gastrointestinal upset. Alcohol can increase the risk of lactic acidosis with metformin and should be limited. Patients should avoid operating heavy machinery until they know how the medication affects them, especially during the first few days of therapy.

## Safety Information 

### ⚠️ Who Should Not Take Kombiglyze XR 

- Individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²) 
- Patients with a history of metabolic acidosis, including lactic acidosis 
- Those with known hypersensitivity to saxagliptin, metformin, or any tablet excipients 
- Patients with acute or chronic heart failure where metformin use is contraindicated 

### Common Side Effects 

- **Gastrointestinal discomfort** - nausea, diarrhoea, abdominal pain; usually mild and improve with continued use. 
- **Upper respiratory symptoms** - nasal congestion or sore throat, occurring in a small proportion of patients. 
- **Headache** - transient and generally self-limiting. 
Management typically involves taking the tablet with a substantial meal and maintaining adequate hydration. 

### Serious Side Effects (Seek Immediate Medical Help) 

- **Lactic acidosis** - characterised by rapid breathing, severe abdominal pain, muscle weakness, and a feeling of coldness. This is rare but life-threatening and requires urgent treatment. 
- **Severe hypersensitivity reactions** - skin rash, swelling, or difficulty breathing. 
- **Pancreatitis** - persistent upper-abdominal pain radiating to the back, accompanied by nausea or vomiting. 

If any of these symptoms develop, contact emergency services without delay. 

### Drug & Food Interactions 

- **CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) - may increase saxagliptin concentrations; dose adjustment or avoidance may be necessary. 
- **Contrast media** - iodinated contrast agents can impair renal function; assess kidney function before use and withhold metformin for 48 hours after the procedure if renal function is compromised. 
- **Other antidiabetic agents** - concomitant sulfonylureas or insulin can amplify hypoglycaemia; dose reductions may be required. 
- **Alcohol** - can predispose to lactic acidosis; limit intake. 
- **Cimetidine** - may increase metformin levels; monitor for gastrointestinal side effects. 

Awareness of these interactions helps prevent adverse events and optimises therapeutic outcomes. 

## Off-Label and Investigational Uses of Kombiglyze XR 

Clinical investigations have explored the cardiovascular safety profile of saxagliptin, showing neutral effects on major adverse cardiac events in the SAVOR-TIMI 53 trial. Some physicians occasionally consider Kombiglyze XR for patients with pre-diabetes who exhibit progressive hyperglycaemia, although regulatory approval for this indication is lacking. Small pilot studies have also examined the combination’s impact on non-alcoholic fatty liver disease, suggesting modest improvements in liver enzymes, but evidence remains insufficient for routine use. All off-label applications should be pursued only under specialist supervision, with careful monitoring of efficacy and safety. 

## Storage & Handling 

- **Temperature** - Store at controlled room temperature between 20 °C and 25 °C (68 °F-77 °F). Protect from excessive heat and humidity. 
- **Light** - Keep the container tightly closed and protect from direct sunlight. 
- **Expiry** - Do not use beyond the expiry date printed on the packaging. 
- **Disposal** - If a tablet is no longer needed, discard it in accordance with local pharmaceutical waste regulations, or return it to a pharmacy for safe disposal. 

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel abroad with Kombiglyze XR?** 
 Yes, you may carry the medication in its original labelled container, accompanied by a copy of your prescription if required. Check the destination country’s import regulations for oral antidiabetic drugs before departure. 

- **Should I take the tablet with breakfast or dinner?** 
 It is advisable to take Kombiglyze XR with the first main meal of the day, ensuring food is present to reduce gastrointestinal side effects and to provide consistent absorption. 

- **Will high-intensity exercise affect my blood sugar while on this medication?** 
 Vigorous activity can increase insulin sensitivity, potentially lowering glucose levels further. Monitor blood glucose before and after exercise, and adjust carbohydrate intake if you notice hypoglycaemia. 

**Product & Formulation Details** 

- **What does a Kombiglyze XR tablet look like?** 
 The tablet is film-coated, white to off-white, and is marked with the dose strength (e.g., “5/500” or “5/1000”) on one side. 

- **Can the tablet be split or crushed?** 
 The extended-release formulation must be swallowed whole; splitting or crushing can alter the release profile and increase the risk of gastrointestinal irritation. 

- **Are there any inactive ingredients I should be aware of?** 
 Inactive components include hypromellose, microcrystalline cellulose, polyethylene glycol, and magnesium stearate. Patients with known hypersensitivity to any of these should consult a pharmacist. 

**Regulatory & Safety Nuances** 

- **Is Kombiglyze XR safe for people with mild kidney disease?** 
 It can be used in patients with an eGFR of 45 mL/min/1.73 m² or higher, but dose reduction is recommended. Those with more advanced renal impairment should avoid the drug. 

- **Will this medication show up on a standard sports drug test?** 
 Neither saxagliptin nor metformin are listed as prohibited substances by major sporting bodies; however, athletes should verify with their governing organization. 

- **Can I purchase Kombiglyze XR without a prescription in the UK?** 
 No, it is a prescription-only medicine. You will need a valid prescription from a qualified prescriber before obtaining it from any pharmacy, including online services. 

**Scientific & Clinical Curiosity** 

- **How does the efficacy of Kombiglyze XR compare with separate tablets of saxagliptin and metformin?** 
 Bioequivalence studies have demonstrated that the fixed-dose combination provides the same plasma concentrations and glycaemic outcomes as taking the two agents individually, while offering the convenience of a single tablet. 

- **When was the combination approved for use in Europe?** 
 The European Medicines Agency granted marketing authorisation for the saxagliptin/metformin XR combination in 2015, following successful Phase III trials that confirmed its safety and efficacy. 

## Glossary 

**DPP-4 inhibitor** 
: A class of drugs that block the enzyme dipeptidyl-peptidase-4, thereby prolonging the activity of incretin hormones which stimulate insulin release after meals. 

**Extended-release (XR)** 
: A formulation designed to release the active ingredient slowly over an extended period, allowing once-daily dosing and reducing peak-related side effects. 

**HbA₁c** 
: Hemoglobin A1c, a laboratory measure that reflects average blood glucose levels over the previous 2-3 months; a key indicator of diabetes control. 

**eGFR** 
: Estimated glomerular filtration rate, an assessment of kidney function expressed in millilitres per minute per 1.73 m² of body-surface area. 

**Lactic acidosis** 
: A rare but serious metabolic complication characterised by the accumulation of lactate in the blood, often associated with impaired metformin clearance. 

## Disclaimer 

The information supplied about **Kombiglyze XR** is intended for general educational purposes and does not replace professional medical advice. Treatment choices, including any off-label applications, should be directed by a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health decisions. [our online pharmacy](https://ayudadiabetes.com/order-kombiglyze-xr-online-en) provides access to Kombiglyze XR for individuals who may encounter limited availability or high costs through conventional channels, including affordable generic alternatives. Always discuss any medication changes with your doctor before initiating, altering, or stopping therapy.